Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog

Circulation Research

Volumn 83, Issue 10, 1998, Pages 969-979

  Recchia, Fabio A ^a   McConnell, Patrick I ^a   Bernstein, Robert D ^a   Vogel, Traci R ^a   Xu, Xiaobin ^a   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Free fatty acid; Glucose; Lactate; MVO2; Respiratory quotient

Indexed keywords

FATTY ACID; GLUCOSE; LACTIC ACID; N(G) NITROARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; DOG; GLUCOSE METABOLISM; HEART FAILURE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART PACING; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY QUOTIENT; SYSTOLIC BLOOD PRESSURE;

EID: 0032539036     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.10.969     Document Type: Article

References (59)

1. De Belder AJ, Radomski MW, Why HJF, Richardson PJ, Bucknall CA, Salas E, Martin JF, Moncada S. Nitric oxide activities in human myocardium. Lancet. 1993;341:84-85.
2. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 1995;92:2198-2203.
3. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
4. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
5. Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265: H176-H182.
6. Weyrich AS, Ma X-L, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JM, Thomas AP, Lefer DJ, Vinten-Johansen J. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res. 1994;75:692-700.
7. Winlaw DS, Smythe GA, Keogh AM, Schyvens CG, Spratt PM, Macdonald PS. Increased nitric oxide production in heart failure. Lancet. 1994;344:373-374.
8. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987;1:355-357.
9. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock. 1993;41:77-81.
10. Elsner D, Muntze A, Kromer EP, Riegger GAJ. Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure. Cardiovasc Res. 1991;25:438-440.
11. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, Zelis R. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992;69:1596-1601.
12. Mohri M, Egashira K, Tagawa T, Kuga T, Tagawa H, Harasawa Y, Shimokawa H, Takeshita A. Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. Hypertension. 1997;30:50-56.
13. Wang J, Seyedi N, Xu XB, Wolin MS, Hintze TH. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol. 1994;266:H670-H680.
14. Kichuk MR, Seyedi N, Zhang XP, Marboe CC, Michler RE, Addonizio LJ, Kaley G, Nasjletti A, Hintze TH. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation. 1996;94:44-51.
15. Smith CJ, Sun D, Hoegler C, Roth BS, Zhang XP, Zhao G, Xu X-B, Kobari Y, Pritchard K Jr, Sessa WC, Hintze TH. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res. 1996;78:58-64.
16. Xie Y-W, Shen W, Zhao G, Xu XB, Wolin MS, Hintze TH. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Circ Res. 1996;79:381-387.
17. Bernstein RD, Ochoa FY, Xu XB, Forfia P, Shen W, Thompson CI, Hintze TH. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res. 1996;79: 840-848.
18. Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen W, Kaminski PM, Wolin MS, Hintze TH. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation. 1995;91:2982-2988.
19. Eckenhoff JE, Hafkenschiel JH, Landmesser CM. The coronary circulation in the dog. Am J Physiol. 1947;148:582-596.
20. Davenport HW. The ABC of Acid-Base Chemistry. Chicago, Ill: University of Chicago Press; 1969:17-53.
21. Duhm J. Effects of 2,3-diphosphoglycerate and other organic phosphate compounds on oxygen affinity and intracellular pH of human erythrocytes. Pflugers Arch. 1971;326:341-356.
22. Oser BL. Hawks Physiological Chemistry. 14th ed. New York, NY: McGraw-Hill Publishing Co; 1965:900-905.
23. Lehninger AL. Principles of Biochemistry. New York, NY: Worth Publishers, Inc; 1982:369.
24. Kaye DM, Chin-Dusting J, Esler MD, Jennings GL. The failing heart does not release nitrogen oxides. Life Sci. 1998;62:883-887.
25. Bernstein RD, Zhang X, Zhao G, Forfia P, Tuzman J, Ochoa F, Ochoa M, Vogel T, Hintze T. Mechanisms of nitrate accumulation in plasma during pacing-induced heart failure in conscious dogs. Nitric Oxide. 1997;5: 386-396.
26. Mohan P, Brutsaert DL, Paulus WJ, Sys SU. Myocardial contractile response to nitric oxide and cGMP. Circulation. 1996;93:1223-1229.
27. Forfia PR, Zhang XP, Ochoa F, Ochoa M, Xu XB, Bernstein R, Sehgal PB, Ferreri NR, Hintze TH. Relationship between plasma NOx and cardiac and vascular dysfunction after lipopolysaccharide injection in anesthetized dogs. Am J Physiol. 1998;274:H193-H201.
28. Sakinis A, Wennmalm A. Estimation of total rate of formation of nitric oxide in the rat. Biochem J. 1998;330:527-532.
29. Shannon RP, Komamura K, Shen YT, Bishop SP, Vatner SF. Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure. Am J Physiol. 1993;265:H801-H809.
30. Gunn RB, Wieth JO, Tosteson DC. Some effects of low pH on chloride exchange in human red blood cells. J Gen Physiol. 1975;65:731-749.
31. Kaiser L, Spickard RC, Olivier NB. Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol. 1989;256: H962-H967.
32. Katz SD, Schwarz M, Yuen J, LeJemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure: role of endothelium-derived vasodilating and vasoconstricting factors. Circulation. 1993;88:55-61.
33. Rose CP, Goresky CA. Interactions between capillary exchange, cellular entry, and metabolic sequestration processes in the heart. In: Renkin EM, Michel CC, eds. Handbook of Physiology: The Cardiovascular System, Microcirculation. Bethesda, Md: American Physiological Society; 1984: 781-798.
34. Knowles RG, Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem Sci. 1992;17:399-402.
35. Shah AM. Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res. 1996;31:847-867.
36. 2+ in intact cardiac myocytes. Circ Res. 1994;74:970-978.
37. Prendergast BD, Sagach VF, Shah AM. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation. 1997;96:1320-1329.
38. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in man. Circulation. 1994;89:2070-2078.
39. Elkayam U. Nitrates in the treatment of congestive heart failure. Am J Cardiol. 1996;77:41C-51C.
40. Packer M. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure? J Am Coll Cardiol. 1996;28:1323-1327.
41. Zhang XP, Xie Y-W, Nasjletti A, Xu XB, Wolin MS, Hintze TH. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation. 1997;95:176-182.
42. Wolff MR, de Tombe PP, Harasawa Y, Burkhoff D, Bier S, Hunter WC, Gerstenblith G, Kass DA. Alterations in left ventricular mechanics, energetics and contractile reserve in experimental heart failure. Circ Res. 1992;70:516-529.
43. Hayashi Y, Takeuchi M, Takaoka H, Hata K, Mori M, Yokoyama M. Alteration in energetics in patients with left ventricular dysfunction after myocardial infarction. Circulation. 1996;93:932-939.
44. Schweizer M, Richter C. Nitric oxide potently and reversibly de-energizes mitochondria at low oxygen tension. Biochem Biophys Res Commun. 1994;204:169-175.
45. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 1994;356:295-298.
46. Shen W, Xu XB, Ochoa M, Zhao G, Wolin MS, Hintze TH. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res. 1994;75:1086-1095.
47. 2+ current. J Biol Chem. 1993;268:26286-26295.
48. Meszaros LG, Minarovic I, Zahradnikova A. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett. 1996;380:49-52.
49. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Cardiovasc Res. 1997;33:243-257.
50. Olson RE. Myocardial metabolism in congestive heart failure. J Chron Dis. 1959;9:442-447.
51. Wittels B, Spann JF Jr. Defective lipid metabolism in the failing heart. J Clin Invest. 1968;47:1787-1794.
52. Feinendegen LE, Henrich MM, Kuikka JT, Thompson KH, Vester EG, Strauer B. Myocardial lipid turnover in dilated cardiomyopathy: a dual in vivo tracer approach. J Nucl Cardiol. 1995;2:42-52.
53. 2+ transport. Circ Res. 1995;77:88-97.
54. Stone CK, Holden J, Stanley WC, Perlman SB. Effect of substrate availability upon cardiac glucose uptake. J Nucl Med. 1995;36:996-1002.
55. Sack MN, Rader TA, Sonhee P, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996;94:2837-2842.
56. Kobayashi A, Masumura Y, Yamazaki N. L-Carnitine treatment for congestive heart failure: experimental and clinical study. Jpn Circ J. 1992; 56:86-94.
57. Zhang J, Snyder SH. Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A. 1992;89:9382-9385.
58. Baron AD. The coupling of glucose metabolism and perfusion in human skeletal muscle: the potential role of endothelium-derived nitric oxide. Diabetes. 1996;45:S105-S109.
59. Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, Radda GK, Ferrannini E. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. J Clin Invest. 1996;98: 2094-2099.